| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.27 | 0.0004 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0009 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |